title: Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells.
abstract: The regulation of human bone marrow stromal precursor cell differentiation toward the chondrocyte, osteoblast or adipocyte lineages is not known. In this study, we assessed the lineage-specific differentiation and conversion of immortalized clonal F/STRO-1(+) A human fetal bone marrow stromal cells under the control of dexamethasone (Dex), indomethacin/insulin (Indo/Ins) and linoleic acid (LA). Under basal conditions, F/STRO-1(+) A cells expressed markers mRNAs or proteins of the osteoblast lineage [CBFA1, osteocalcin (OC), alkaline phosphatase (ALP), type 1 collagen], of the chondrocyte lineage (aggrecan, types 2, 9 and 10 collagen), and of the adipocyte lineage (PPARgamma2, C/EBPalpha, aP2, G3PDH, lipoprotein lipase, leptin). Treatment with Dex increased CBFA1, OC and ALP mRNA and protein levels. Exposure to LA enhanced expression of adipocytic genes and cytoplasmic triglycerides accumulation, and suppressed the Dex-induced stimulation of osteoblast marker genes. Indo/Ins stimulated the synthesis of aggrecan and type 2 collagen and increased types 9 and 10 collagen mRNA levels, and suppressed both basal and Dex-promoted expression of osteoblast markers. Conversely, stimulation of osteoblastogenesis by Dex suppressed both basal and Indo/Ins-stimulated chondrocyte genes. Thus, the clonal human fetal bone marrow stromal F/STRO-1(+) A cell line is a lineage-unrestricted common progenitor that expresses tripotential adipocyte, osteoblast or chondrocyte characteristics. Our data also show that differentiation towards one pathway in response to Dex, Indo/Ins and LA restricts expression of other lineage-specific genes, and provide evidence for a controlled reciprocal regulation of osteoblast/chondroblast and osteoblast/adipocyte differentiation of clonal F/STRO-1(+) human bone marrow stromal cells.
authors.affiliation: INSERM Unité 349 affiliated CNRS, Lariboisière Hospital, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France.
authors.forename: S
authors.initials: S
authors.lastname: Ahdjoudj
authors.forename: F
authors.initials: F
authors.lastname: Lasmoles
authors.forename: B O
authors.initials: BO
authors.lastname: Oyajobi
authors.forename: A
authors.initials: A
authors.lastname: Lomri
authors.forename: P
authors.initials: P
authors.lastname: Delannoy
authors.forename: P J
authors.initials: PJ
authors.lastname: Marie
mesh_terms: D017667:Adipocytes / Q000166:cytology*; D001483:Base Sequence; D001854:Bone Marrow Cells / Q000166:cytology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D019902:Chondrocytes / Q000166:cytology*; D017931:DNA Primers; D003907:Dexamethasone / Q000494:pharmacology; D015151:Immunoblotting; D010006:Osteoblasts / Q000166:cytology*; D017154:Stromal Cells / Q000166:cytology*
chemical_list: D017931:DNA Primers; D003907:Dexamethasone